X4 Pharmaceuticals - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $98,995.00 +1.32%
Ethereum $3,304.70 -1.30%
BNB $624.10 +0.62%
Optimism $2.12 +0.29%
Arbitrum $0.78 -0.98%
Solana $254.65 -1.30%
Polygon $0.47 +4.53%
Cosmos $7.31 +15.40%
Avalanche $39.73 +11.71%

Bitcoin $98,995.00 +1.32%
Ethereum $3,304.70 -1.30%
BNB $624.10 +0.62%
Optimism $2.12 +0.29%
Arbitrum $0.78 -0.98%
Solana $254.65 -1.30%
Polygon $0.47 +4.53%
Cosmos $7.31 +15.40%
Avalanche $39.73 +11.71%

X4 Pharmaceuticals

company

Investors

Number of Lead Investors

Number of Investors

5

17

X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Acorn Bioventures	Yes	Post-IPO Equity
Lumira Ventures	Yes	Post-IPO Equity
New Enterprise Associates	Yes	Post-IPO Equity
Cormorant Asset Management	Yes	Series B
Hercules Capital	-	Post-IPO Equity
AXA Investment Managers	-	Post-IPO Equity
Bain Capital Life Sciences	-	Post-IPO Equity
OrbiMed	-	Post-IPO Equity
Abingworth	-	Post-IPO Equity
Altium Capital	-	Post-IPO Equity
Driehaus Capital Management	-	Post-IPO Equity
Ikarian Capital	-	Post-IPO Equity
Lincoln Park Capital Fund	-	Post-IPO Equity
Monashee Investment Management	-	Post-IPO Equity
Sio Capital Management	-	Post-IPO Equity
Thynk Capital, LLC.	-	Series A
SV Health Investors	-	Seed